nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—FGFR3—skull—pharynx cancer	0.0345	0.0507	CbGeAlD
Pazopanib—FGFR2—skull—pharynx cancer	0.0226	0.0332	CbGeAlD
Pazopanib—MAP3K9—epithelium—pharynx cancer	0.0117	0.0172	CbGeAlD
Pazopanib—LIMK2—mouth—pharynx cancer	0.0104	0.0152	CbGeAlD
Pazopanib—RIOK2—parotid gland—pharynx cancer	0.00831	0.0122	CbGeAlD
Pazopanib—FGF1—mouth—pharynx cancer	0.00827	0.0122	CbGeAlD
Pazopanib—FGFR2—mouth—pharynx cancer	0.00781	0.0115	CbGeAlD
Pazopanib—ITK—lymphoid tissue—pharynx cancer	0.00745	0.011	CbGeAlD
Pazopanib—PI4KB—parotid gland—pharynx cancer	0.00735	0.0108	CbGeAlD
Pazopanib—SH2B3—trachea—pharynx cancer	0.00733	0.0108	CbGeAlD
Pazopanib—MAP3K9—head—pharynx cancer	0.00728	0.0107	CbGeAlD
Pazopanib—FGF1—neck—pharynx cancer	0.00707	0.0104	CbGeAlD
Pazopanib—PI4KB—saliva-secreting gland—pharynx cancer	0.00704	0.0103	CbGeAlD
Pazopanib—FGFR3—epithelium—pharynx cancer	0.00694	0.0102	CbGeAlD
Pazopanib—BMPR1B—epithelium—pharynx cancer	0.00687	0.0101	CbGeAlD
Pazopanib—FGFR2—neck—pharynx cancer	0.00668	0.00981	CbGeAlD
Pazopanib—PIP4K2C—parotid gland—pharynx cancer	0.00645	0.00948	CbGeAlD
Pazopanib—SH2B3—lymphoid tissue—pharynx cancer	0.00639	0.00939	CbGeAlD
Pazopanib—FLT1—neck—pharynx cancer	0.00619	0.0091	CbGeAlD
Pazopanib—PIP4K2C—saliva-secreting gland—pharynx cancer	0.00618	0.00908	CbGeAlD
Pazopanib—TAOK1—spinal cord—pharynx cancer	0.00615	0.00904	CbGeAlD
Pazopanib—SH2B3—spinal cord—pharynx cancer	0.00579	0.00851	CbGeAlD
Pazopanib—PLK4—lymphoid tissue—pharynx cancer	0.00575	0.00845	CbGeAlD
Pazopanib—STK36—trachea—pharynx cancer	0.00551	0.0081	CbGeAlD
Pazopanib—TAOK1—head—pharynx cancer	0.00547	0.00803	CbGeAlD
Pazopanib—STK16—lymphoid tissue—pharynx cancer	0.00543	0.00798	CbGeAlD
Pazopanib—PI4KB—trachea—pharynx cancer	0.00543	0.00798	CbGeAlD
Pazopanib—KIT—mouth—pharynx cancer	0.00542	0.00797	CbGeAlD
Pazopanib—FLT4—epithelium—pharynx cancer	0.00542	0.00796	CbGeAlD
Pazopanib—FGF1—brainstem—pharynx cancer	0.0054	0.00794	CbGeAlD
Pazopanib—LYN—lymphoid tissue—pharynx cancer	0.00537	0.0079	CbGeAlD
Pazopanib—LIMK2—trachea—pharynx cancer	0.00533	0.00783	CbGeAlD
Pazopanib—KDR—neck—pharynx cancer	0.00523	0.00769	CbGeAlD
Pazopanib—FGFR2—saliva-secreting gland—pharynx cancer	0.00521	0.00766	CbGeAlD
Pazopanib—SH2B3—head—pharynx cancer	0.00515	0.00756	CbGeAlD
Pazopanib—FGFR2—brainstem—pharynx cancer	0.0051	0.0075	CbGeAlD
Pazopanib—MAP3K9—lymph node—pharynx cancer	0.0051	0.00749	CbGeAlD
Pazopanib—AURKC—head—pharynx cancer	0.00507	0.00745	CbGeAlD
Pazopanib—FLT1—parotid gland—pharynx cancer	0.00504	0.00741	CbGeAlD
Pazopanib—EPHB6—parotid gland—pharynx cancer	0.00498	0.00732	CbGeAlD
Pazopanib—RIOK2—spinal cord—pharynx cancer	0.00485	0.00712	CbGeAlD
Pazopanib—FGFR3—spinal cord—pharynx cancer	0.00485	0.00712	CbGeAlD
Pazopanib—FLT1—saliva-secreting gland—pharynx cancer	0.00483	0.0071	CbGeAlD
Pazopanib—FGF1—epithelium—pharynx cancer	0.00481	0.00707	CbGeAlD
Pazopanib—EPHB6—saliva-secreting gland—pharynx cancer	0.00477	0.00701	CbGeAlD
Pazopanib—PIP4K2C—trachea—pharynx cancer	0.00476	0.007	CbGeAlD
Pazopanib—TAOK3—parotid gland—pharynx cancer	0.00475	0.00699	CbGeAlD
Pazopanib—LIMK2—lymphoid tissue—pharynx cancer	0.00464	0.00682	CbGeAlD
Pazopanib—KIT—neck—pharynx cancer	0.00464	0.00682	CbGeAlD
Pazopanib—TAOK3—saliva-secreting gland—pharynx cancer	0.00455	0.00669	CbGeAlD
Pazopanib—FGFR2—epithelium—pharynx cancer	0.00454	0.00668	CbGeAlD
Pazopanib—PDGFRB—neck—pharynx cancer	0.00453	0.00666	CbGeAlD
Pazopanib—TAOK3—brainstem—pharynx cancer	0.00446	0.00656	CbGeAlD
Pazopanib—STK16—head—pharynx cancer	0.00438	0.00643	CbGeAlD
Pazopanib—LYN—head—pharynx cancer	0.00433	0.00636	CbGeAlD
Pazopanib—FGFR3—head—pharynx cancer	0.00431	0.00633	CbGeAlD
Pazopanib—RIOK2—head—pharynx cancer	0.00431	0.00633	CbGeAlD
Pazopanib—PI4KB—spinal cord—pharynx cancer	0.00429	0.0063	CbGeAlD
Pazopanib—MAP3K19—head—pharynx cancer	0.00427	0.00627	CbGeAlD
Pazopanib—BMPR1B—head—pharynx cancer	0.00427	0.00627	CbGeAlD
Pazopanib—KDR—parotid gland—pharynx cancer	0.00426	0.00626	CbGeAlD
Pazopanib—MAP2K5—parotid gland—pharynx cancer	0.00426	0.00626	CbGeAlD
Pazopanib—LCK—trachea—pharynx cancer	0.00423	0.00622	CbGeAlD
Pazopanib—FLT1—epithelium—pharynx cancer	0.00421	0.00619	CbGeAlD
Pazopanib—LIMK2—spinal cord—pharynx cancer	0.00421	0.00619	CbGeAlD
Pazopanib—ITK—lymph node—pharynx cancer	0.00421	0.00618	CbGeAlD
Pazopanib—FLT4—lymphoid tissue—pharynx cancer	0.00417	0.00613	CbGeAlD
Pazopanib—KDR—saliva-secreting gland—pharynx cancer	0.00408	0.006	CbGeAlD
Pazopanib—MAP2K5—saliva-secreting gland—pharynx cancer	0.00408	0.006	CbGeAlD
Pazopanib—MAP2K5—brainstem—pharynx cancer	0.004	0.00588	CbGeAlD
Pazopanib—MAP3K2—lymphoid tissue—pharynx cancer	0.00393	0.00578	CbGeAlD
Pazopanib—STK36—head—pharynx cancer	0.00387	0.00569	CbGeAlD
Pazopanib—TAOK1—lymph node—pharynx cancer	0.00383	0.00563	CbGeAlD
Pazopanib—PI4KB—head—pharynx cancer	0.00381	0.0056	CbGeAlD
Pazopanib—KIT—parotid gland—pharynx cancer	0.00378	0.00555	CbGeAlD
Pazopanib—PIP4K2C—spinal cord—pharynx cancer	0.00376	0.00553	CbGeAlD
Pazopanib—LIMK2—head—pharynx cancer	0.00374	0.0055	CbGeAlD
Pazopanib—FGFR1—spinal cord—pharynx cancer	0.00373	0.00548	CbGeAlD
Pazopanib—FLT1—trachea—pharynx cancer	0.00372	0.00547	CbGeAlD
Pazopanib—FGF1—lymphoid tissue—pharynx cancer	0.00371	0.00545	CbGeAlD
Pazopanib—PDGFRB—parotid gland—pharynx cancer	0.00369	0.00542	CbGeAlD
Pazopanib—EPHB6—trachea—pharynx cancer	0.00368	0.00541	CbGeAlD
Pazopanib—KIT—saliva-secreting gland—pharynx cancer	0.00362	0.00532	CbGeAlD
Pazopanib—SH2B3—lymph node—pharynx cancer	0.0036	0.0053	CbGeAlD
Pazopanib—KDR—epithelium—pharynx cancer	0.00356	0.00523	CbGeAlD
Pazopanib—AURKC—lymph node—pharynx cancer	0.00355	0.00521	CbGeAlD
Pazopanib—KIT—brainstem—pharynx cancer	0.00354	0.00521	CbGeAlD
Pazopanib—PDGFRB—saliva-secreting gland—pharynx cancer	0.00353	0.00519	CbGeAlD
Pazopanib—TAOK3—trachea—pharynx cancer	0.00351	0.00516	CbGeAlD
Pazopanib—PDGFRA—trachea—pharynx cancer	0.00349	0.00513	CbGeAlD
Pazopanib—FLT4—head—pharynx cancer	0.00336	0.00494	CbGeAlD
Pazopanib—FGF1—spinal cord—pharynx cancer	0.00336	0.00494	CbGeAlD
Pazopanib—PIP4K2C—head—pharynx cancer	0.00334	0.00491	CbGeAlD
Pazopanib—PLK4—lymph node—pharynx cancer	0.00325	0.00477	CbGeAlD
Pazopanib—FLT1—lymphoid tissue—pharynx cancer	0.00324	0.00477	CbGeAlD
Pazopanib—FGFR2—spinal cord—pharynx cancer	0.00317	0.00466	CbGeAlD
Pazopanib—MAP3K2—head—pharynx cancer	0.00317	0.00466	CbGeAlD
Pazopanib—KIT—epithelium—pharynx cancer	0.00316	0.00464	CbGeAlD
Pazopanib—KDR—trachea—pharynx cancer	0.00315	0.00463	CbGeAlD
Pazopanib—MAP2K5—trachea—pharynx cancer	0.00315	0.00463	CbGeAlD
Pazopanib—PDGFRB—epithelium—pharynx cancer	0.00308	0.00453	CbGeAlD
Pazopanib—CSF1R—trachea—pharynx cancer	0.00307	0.00452	CbGeAlD
Pazopanib—STK10—lymphoid tissue—pharynx cancer	0.00307	0.00451	CbGeAlD
Pazopanib—STK16—lymph node—pharynx cancer	0.00306	0.0045	CbGeAlD
Pazopanib—TAOK3—lymphoid tissue—pharynx cancer	0.00306	0.0045	CbGeAlD
Pazopanib—PDGFRA—lymphoid tissue—pharynx cancer	0.00304	0.00447	CbGeAlD
Pazopanib—RIOK2—lymph node—pharynx cancer	0.00302	0.00443	CbGeAlD
Pazopanib—BMPR1B—lymph node—pharynx cancer	0.00299	0.00439	CbGeAlD
Pazopanib—FGF1—head—pharynx cancer	0.00299	0.00439	CbGeAlD
Pazopanib—FLT1—spinal cord—pharynx cancer	0.00294	0.00432	CbGeAlD
Pazopanib—EPHB6—spinal cord—pharynx cancer	0.00291	0.00427	CbGeAlD
Pazopanib—FGFR2—head—pharynx cancer	0.00282	0.00414	CbGeAlD
Pazopanib—KIT—trachea—pharynx cancer	0.00279	0.0041	CbGeAlD
Pazopanib—TAOK3—spinal cord—pharynx cancer	0.00277	0.00408	CbGeAlD
Pazopanib—PDGFRA—spinal cord—pharynx cancer	0.00276	0.00405	CbGeAlD
Pazopanib—KDR—lymphoid tissue—pharynx cancer	0.00274	0.00403	CbGeAlD
Pazopanib—PDGFRB—trachea—pharynx cancer	0.00273	0.00401	CbGeAlD
Pazopanib—STK36—lymph node—pharynx cancer	0.00271	0.00398	CbGeAlD
Pazopanib—CSF1R—lymphoid tissue—pharynx cancer	0.00268	0.00393	CbGeAlD
Pazopanib—PI4KB—lymph node—pharynx cancer	0.00267	0.00392	CbGeAlD
Pazopanib—LIMK2—lymph node—pharynx cancer	0.00262	0.00385	CbGeAlD
Pazopanib—FLT1—head—pharynx cancer	0.00261	0.00384	CbGeAlD
Pazopanib—EPHB6—head—pharynx cancer	0.00258	0.0038	CbGeAlD
Pazopanib—KDR—spinal cord—pharynx cancer	0.00249	0.00365	CbGeAlD
Pazopanib—MAP2K5—spinal cord—pharynx cancer	0.00249	0.00365	CbGeAlD
Pazopanib—STK10—head—pharynx cancer	0.00247	0.00364	CbGeAlD
Pazopanib—TAOK3—head—pharynx cancer	0.00247	0.00362	CbGeAlD
Pazopanib—PDGFRA—head—pharynx cancer	0.00245	0.0036	CbGeAlD
Pazopanib—KIT—lymphoid tissue—pharynx cancer	0.00243	0.00357	CbGeAlD
Pazopanib—CSF1R—spinal cord—pharynx cancer	0.00243	0.00357	CbGeAlD
Pazopanib—PDGFRB—lymphoid tissue—pharynx cancer	0.00237	0.00349	CbGeAlD
Pazopanib—FLT4—lymph node—pharynx cancer	0.00235	0.00346	CbGeAlD
Pazopanib—PIP4K2C—lymph node—pharynx cancer	0.00234	0.00344	CbGeAlD
Pazopanib—FGFR1—lymph node—pharynx cancer	0.00232	0.00341	CbGeAlD
Pazopanib—MAP3K2—lymph node—pharynx cancer	0.00222	0.00326	CbGeAlD
Pazopanib—MAP2K5—head—pharynx cancer	0.00221	0.00325	CbGeAlD
Pazopanib—KDR—head—pharynx cancer	0.00221	0.00325	CbGeAlD
Pazopanib—KIT—spinal cord—pharynx cancer	0.0022	0.00324	CbGeAlD
Pazopanib—CSF1R—head—pharynx cancer	0.00216	0.00317	CbGeAlD
Pazopanib—PDGFRB—spinal cord—pharynx cancer	0.00215	0.00316	CbGeAlD
Pazopanib—FGF1—lymph node—pharynx cancer	0.00209	0.00307	CbGeAlD
Pazopanib—LCK—lymph node—pharynx cancer	0.00208	0.00305	CbGeAlD
Pazopanib—ABCG2—parotid gland—pharynx cancer	0.00207	0.00305	CbGeAlD
Pazopanib—ABCG2—saliva-secreting gland—pharynx cancer	0.00199	0.00292	CbGeAlD
Pazopanib—KIT—head—pharynx cancer	0.00196	0.00288	CbGeAlD
Pazopanib—PDGFRB—head—pharynx cancer	0.00191	0.00281	CbGeAlD
Pazopanib—FLT1—lymph node—pharynx cancer	0.00183	0.00269	CbGeAlD
Pazopanib—EPHB6—lymph node—pharynx cancer	0.00181	0.00266	CbGeAlD
Pazopanib—STK10—lymph node—pharynx cancer	0.00173	0.00255	CbGeAlD
Pazopanib—TAOK3—lymph node—pharynx cancer	0.00173	0.00254	CbGeAlD
Pazopanib—PDGFRA—lymph node—pharynx cancer	0.00172	0.00252	CbGeAlD
Pazopanib—KDR—lymph node—pharynx cancer	0.00155	0.00227	CbGeAlD
Pazopanib—MAP2K5—lymph node—pharynx cancer	0.00155	0.00227	CbGeAlD
Pazopanib—CSF1R—lymph node—pharynx cancer	0.00151	0.00222	CbGeAlD
Pazopanib—KIT—lymph node—pharynx cancer	0.00137	0.00202	CbGeAlD
Pazopanib—PDGFRB—lymph node—pharynx cancer	0.00134	0.00197	CbGeAlD
Pazopanib—CYP2D6—brainstem—pharynx cancer	0.00133	0.00196	CbGeAlD
Pazopanib—ABCG2—spinal cord—pharynx cancer	0.00121	0.00178	CbGeAlD
Pazopanib—ABCB1—epithelium—pharynx cancer	0.000854	0.00126	CbGeAlD
Pazopanib—ABCB1—trachea—pharynx cancer	0.000755	0.00111	CbGeAlD
Pazopanib—ABCG2—lymph node—pharynx cancer	0.000753	0.00111	CbGeAlD
Pazopanib—CYP2D6—head—pharynx cancer	0.000737	0.00108	CbGeAlD
Pazopanib—ABCB1—lymphoid tissue—pharynx cancer	0.000658	0.000967	CbGeAlD
Pazopanib—ABCB1—spinal cord—pharynx cancer	0.000596	0.000877	CbGeAlD
Pazopanib—ABCB1—head—pharynx cancer	0.00053	0.000779	CbGeAlD
Pazopanib—PDGFRA—Signaling by ERBB2—EGFR—pharynx cancer	0.000386	0.00121	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CNDP2—pharynx cancer	0.000385	0.00121	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by EGFR—EGFR—pharynx cancer	0.000385	0.0012	CbGpPWpGaD
Pazopanib—FGFR1—DAP12 signaling—EGFR—pharynx cancer	0.000385	0.0012	CbGpPWpGaD
Pazopanib—FGFR3—Signaling by NGF—EGFR—pharynx cancer	0.000385	0.0012	CbGpPWpGaD
Pazopanib—PDGFRA—DAP12 signaling—EGFR—pharynx cancer	0.000384	0.0012	CbGpPWpGaD
Pazopanib—LYN—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000382	0.0012	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000381	0.00119	CbGpPWpGaD
Pazopanib—KIT—DAP12 interactions—EGFR—pharynx cancer	0.000381	0.00119	CbGpPWpGaD
Pazopanib—KIT—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000381	0.00119	CbGpPWpGaD
Pazopanib—KIT—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000381	0.00119	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—B4GALT5—pharynx cancer	0.000381	0.00119	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by PDGF—EGFR—pharynx cancer	0.00038	0.00119	CbGpPWpGaD
Pazopanib—FGFR1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000379	0.00119	CbGpPWpGaD
Pazopanib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000378	0.00118	CbGpPWpGaD
Pazopanib—KIT—Signaling by EGFR—EGFR—pharynx cancer	0.000378	0.00118	CbGpPWpGaD
Pazopanib—FGFR1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000377	0.00118	CbGpPWpGaD
Pazopanib—LIMK2—Developmental Biology—EGFR—pharynx cancer	0.000377	0.00118	CbGpPWpGaD
Pazopanib—ITK—Adaptive Immune System—EGFR—pharynx cancer	0.000376	0.00118	CbGpPWpGaD
Pazopanib—KIT—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000375	0.00117	CbGpPWpGaD
Pazopanib—PDGFRB—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000373	0.00117	CbGpPWpGaD
Pazopanib—PDGFRB—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.000373	0.00117	CbGpPWpGaD
Pazopanib—KIT—Signaling by PDGF—EGFR—pharynx cancer	0.000373	0.00117	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD79A—pharynx cancer	0.000372	0.00117	CbGpPWpGaD
Pazopanib—ABCB1—lymph node—pharynx cancer	0.000371	0.000545	CbGeAlD
Pazopanib—FGF1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000371	0.00116	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by ERBB4—EGFR—pharynx cancer	0.000367	0.00115	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD79A—pharynx cancer	0.000365	0.00114	CbGpPWpGaD
Pazopanib—FGFR1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000362	0.00113	CbGpPWpGaD
Pazopanib—FGFR1—DAP12 interactions—EGFR—pharynx cancer	0.000362	0.00113	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000362	0.00113	CbGpPWpGaD
Pazopanib—PDGFRA—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000361	0.00113	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000361	0.00113	CbGpPWpGaD
Pazopanib—PDGFRA—DAP12 interactions—EGFR—pharynx cancer	0.000361	0.00113	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—CDH1—pharynx cancer	0.00036	0.00113	CbGpPWpGaD
Pazopanib—FGFR2—B Cell Activation—EGFR—pharynx cancer	0.000359	0.00112	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by EGFR—EGFR—pharynx cancer	0.000359	0.00112	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by EGFR—EGFR—pharynx cancer	0.000358	0.00112	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000356	0.00111	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000355	0.00111	CbGpPWpGaD
Pazopanib—EPHB6—Developmental Biology—EGFR—pharynx cancer	0.000354	0.00111	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by PDGF—EGFR—pharynx cancer	0.000354	0.00111	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CNDP2—pharynx cancer	0.000353	0.00111	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by PDGF—EGFR—pharynx cancer	0.000353	0.0011	CbGpPWpGaD
Pazopanib—KIT—B Cell Activation—EGFR—pharynx cancer	0.000353	0.0011	CbGpPWpGaD
Pazopanib—PDGFRB—Downstream signal transduction—EGFR—pharynx cancer	0.000351	0.0011	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by FGFR—EGFR—pharynx cancer	0.000349	0.00109	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ADH7—pharynx cancer	0.000349	0.00109	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by ERBB2—EGFR—pharynx cancer	0.000347	0.00109	CbGpPWpGaD
Pazopanib—PDGFRB—DAP12 signaling—EGFR—pharynx cancer	0.000346	0.00108	CbGpPWpGaD
Pazopanib—FGFR2—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000344	0.00108	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling by NGF—EGFR—pharynx cancer	0.000344	0.00108	CbGpPWpGaD
Pazopanib—PDGFRA—Focal Adhesion—EGFR—pharynx cancer	0.000341	0.00107	CbGpPWpGaD
Pazopanib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000341	0.00107	CbGpPWpGaD
Pazopanib—FGFR1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000341	0.00107	CbGpPWpGaD
Pazopanib—PDGFRA—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00034	0.00106	CbGpPWpGaD
Pazopanib—PDGFRB—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000339	0.00106	CbGpPWpGaD
Pazopanib—KIT—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000338	0.00106	CbGpPWpGaD
Pazopanib—FGFR1—B Cell Activation—EGFR—pharynx cancer	0.000335	0.00105	CbGpPWpGaD
Pazopanib—PDGFRA—B Cell Activation—EGFR—pharynx cancer	0.000334	0.00105	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CNDP2—pharynx cancer	0.000327	0.00102	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD79A—pharynx cancer	0.000326	0.00102	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000325	0.00102	CbGpPWpGaD
Pazopanib—PDGFRB—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000325	0.00102	CbGpPWpGaD
Pazopanib—PDGFRB—DAP12 interactions—EGFR—pharynx cancer	0.000325	0.00102	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by EGFR—EGFR—pharynx cancer	0.000322	0.00101	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000321	0.001	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000321	0.001	CbGpPWpGaD
Pazopanib—FGFR1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000321	0.001	CbGpPWpGaD
Pazopanib—PDGFRA—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00032	0.001	CbGpPWpGaD
Pazopanib—FGF1—Signaling by NGF—EGFR—pharynx cancer	0.00032	0.001	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000319	0.001	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ADH7—pharynx cancer	0.000319	0.001	CbGpPWpGaD
Pazopanib—LYN—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000318	0.000997	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by PDGF—EGFR—pharynx cancer	0.000318	0.000995	CbGpPWpGaD
Pazopanib—FGFR1—MAPK Signaling Pathway—TP53—pharynx cancer	0.000317	0.000992	CbGpPWpGaD
Pazopanib—LCK—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000313	0.00098	CbGpPWpGaD
Pazopanib—PDGFRB—Focal Adhesion—EGFR—pharynx cancer	0.000307	0.000962	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ADH1B—pharynx cancer	0.000306	0.000957	CbGpPWpGaD
Pazopanib—LCK—Disease—B4GALT5—pharynx cancer	0.000306	0.000956	CbGpPWpGaD
Pazopanib—KDR—Axon guidance—EGFR—pharynx cancer	0.000303	0.000949	CbGpPWpGaD
Pazopanib—PDGFRB—B Cell Activation—EGFR—pharynx cancer	0.000301	0.000942	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.0003	0.000938	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—CDH1—pharynx cancer	0.000299	0.000937	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD79A—pharynx cancer	0.000299	0.000936	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ADH7—pharynx cancer	0.000296	0.000926	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB4—EGFR—pharynx cancer	0.000295	0.000923	CbGpPWpGaD
Pazopanib—LYN—B Cell Activation—EGFR—pharynx cancer	0.000295	0.000922	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—B4GALT5—pharynx cancer	0.000292	0.000914	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—CCND1—pharynx cancer	0.000291	0.000912	CbGpPWpGaD
Pazopanib—PDGFRB—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000288	0.000902	CbGpPWpGaD
Pazopanib—FGFR1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000286	0.000895	CbGpPWpGaD
Pazopanib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000285	0.000893	CbGpPWpGaD
Pazopanib—PDGFRB—MAPK Signaling Pathway—TP53—pharynx cancer	0.000285	0.000891	CbGpPWpGaD
Pazopanib—LCK—Downstream signal transduction—EGFR—pharynx cancer	0.000282	0.000881	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR—EGFR—pharynx cancer	0.00028	0.000877	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ADH1B—pharynx cancer	0.00028	0.000877	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB2—EGFR—pharynx cancer	0.000279	0.000873	CbGpPWpGaD
Pazopanib—LCK—DAP12 signaling—EGFR—pharynx cancer	0.000277	0.000868	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000273	0.000856	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD79A—pharynx cancer	0.00027	0.000844	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—B4GALT5—pharynx cancer	0.000268	0.000838	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD79A—pharynx cancer	0.000265	0.000829	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—EGFR—pharynx cancer	0.000265	0.000828	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000261	0.000817	CbGpPWpGaD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000261	0.000817	CbGpPWpGaD
Pazopanib—LCK—DAP12 interactions—EGFR—pharynx cancer	0.000261	0.000817	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—EGFR—pharynx cancer	0.00026	0.000813	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ADH1B—pharynx cancer	0.000259	0.000812	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—EGFR—pharynx cancer	0.000259	0.00081	CbGpPWpGaD
Pazopanib—PLK4—Cell Cycle—TP53—pharynx cancer	0.000257	0.000804	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000256	0.000802	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—EGFR—pharynx cancer	0.000255	0.000799	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD79A—pharynx cancer	0.000251	0.000787	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD79A—pharynx cancer	0.000251	0.000785	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.000248	0.000776	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—CDH1—pharynx cancer	0.000248	0.000775	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—EGFR—pharynx cancer	0.000247	0.000772	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—EGFR—pharynx cancer	0.000246	0.00077	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—CDH1—pharynx cancer	0.000243	0.000762	CbGpPWpGaD
Pazopanib—LCK—B Cell Activation—EGFR—pharynx cancer	0.000242	0.000756	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000231	0.000724	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—CDH1—pharynx cancer	0.000231	0.000723	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CDH1—pharynx cancer	0.00023	0.000721	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—EGFR—pharynx cancer	0.000229	0.000716	CbGpPWpGaD
Pazopanib—ITK—Immune System—EGFR—pharynx cancer	0.000228	0.000713	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD79A—pharynx cancer	0.000226	0.000707	CbGpPWpGaD
Pazopanib—FGFR1—Axon guidance—EGFR—pharynx cancer	0.000223	0.000698	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—EGFR—pharynx cancer	0.000222	0.000693	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD79A—pharynx cancer	0.000221	0.000692	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—EGFR—pharynx cancer	0.000219	0.000687	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CDH1—pharynx cancer	0.000218	0.000684	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—EGFR—pharynx cancer	0.000216	0.000677	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—EGFR—pharynx cancer	0.000211	0.000659	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CDH1—pharynx cancer	0.000207	0.000649	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CDH1—pharynx cancer	0.000203	0.000636	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000203	0.000635	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—CCND1—pharynx cancer	0.000202	0.000632	CbGpPWpGaD
Pazopanib—LYN—Axon guidance—EGFR—pharynx cancer	0.000196	0.000614	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—TP53—pharynx cancer	0.000192	0.000601	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—CCND1—pharynx cancer	0.000185	0.000578	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000184	0.000574	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—EGFR—pharynx cancer	0.000182	0.000571	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CDH1—pharynx cancer	0.000182	0.000568	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD79A—pharynx cancer	0.000181	0.000567	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—EGFR—pharynx cancer	0.000178	0.000556	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000177	0.000553	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—EGFR—pharynx cancer	0.000175	0.000548	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000167	0.000522	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CDH1—pharynx cancer	0.000167	0.000521	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000164	0.000513	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000161	0.000504	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADH7—pharynx cancer	0.00016	0.0005	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—EGFR—pharynx cancer	0.000159	0.000498	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—EGFR—pharynx cancer	0.000159	0.000496	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000154	0.000481	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—EGFR—pharynx cancer	0.000151	0.000472	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000151	0.000472	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CDH1—pharynx cancer	0.00015	0.00047	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—EGFR—pharynx cancer	0.000148	0.000464	CbGpPWpGaD
Pazopanib—KIT—Immune System—CDH1—pharynx cancer	0.000148	0.000462	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—EGFR—pharynx cancer	0.000145	0.000454	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—EGFR—pharynx cancer	0.000145	0.000453	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—EGFR—pharynx cancer	0.000142	0.000445	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000141	0.000442	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—EGFR—pharynx cancer	0.000141	0.00044	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—EGFR—pharynx cancer	0.00014	0.000439	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADH1B—pharynx cancer	0.00014	0.000439	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—EGFR—pharynx cancer	0.00014	0.000438	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CDH1—pharynx cancer	0.00014	0.000438	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CDH1—pharynx cancer	0.00014	0.000437	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—CCND1—pharynx cancer	0.000138	0.000431	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—EGFR—pharynx cancer	0.000135	0.000423	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—EGFR—pharynx cancer	0.000135	0.000422	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000134	0.000419	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—TP53—pharynx cancer	0.000133	0.000417	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000132	0.000414	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000129	0.000403	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—EGFR—pharynx cancer	0.000128	0.0004	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000128	0.0004	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—EGFR—pharynx cancer	0.000126	0.000396	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000126	0.000395	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CDH1—pharynx cancer	0.000126	0.000394	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—EGFR—pharynx cancer	0.000124	0.000387	CbGpPWpGaD
Pazopanib—LYN—Immune System—CDH1—pharynx cancer	0.000123	0.000386	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—TP53—pharynx cancer	0.000122	0.000381	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—EGFR—pharynx cancer	0.000121	0.00038	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—EGFR—pharynx cancer	0.000119	0.000372	CbGpPWpGaD
Pazopanib—FGFR3—Disease—EGFR—pharynx cancer	0.000118	0.000369	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—TP53—pharynx cancer	0.000115	0.000361	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000112	0.00035	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000109	0.000341	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—EGFR—pharynx cancer	0.000108	0.000339	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000108	0.000338	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000107	0.000335	CbGpPWpGaD
Pazopanib—FGF1—Immune System—EGFR—pharynx cancer	0.000106	0.000332	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CCND1—pharynx cancer	0.000105	0.00033	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—EGFR—pharynx cancer	0.000101	0.000317	CbGpPWpGaD
Pazopanib—LCK—Immune System—CDH1—pharynx cancer	0.000101	0.000316	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADH7—pharynx cancer	9.85e-05	0.000308	CbGpPWpGaD
Pazopanib—FGF1—Disease—EGFR—pharynx cancer	9.8e-05	0.000307	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—EGFR—pharynx cancer	9.74e-05	0.000305	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—pharynx cancer	9.46e-05	0.000296	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CCND1—pharynx cancer	9.41e-05	0.000295	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CCND1—pharynx cancer	9.17e-05	0.000287	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—pharynx cancer	9.08e-05	0.000284	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—EGFR—pharynx cancer	8.79e-05	0.000275	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CCND1—pharynx cancer	8.75e-05	0.000274	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADH1B—pharynx cancer	8.64e-05	0.00027	CbGpPWpGaD
Pazopanib—KIT—Immune System—EGFR—pharynx cancer	8.63e-05	0.00027	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—EGFR—pharynx cancer	8.26e-05	0.000259	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—B4GALT5—pharynx cancer	8.26e-05	0.000258	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—EGFR—pharynx cancer	8.19e-05	0.000256	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—EGFR—pharynx cancer	8.17e-05	0.000256	CbGpPWpGaD
Pazopanib—FGFR2—Disease—EGFR—pharynx cancer	8.11e-05	0.000254	CbGpPWpGaD
Pazopanib—KIT—Disease—EGFR—pharynx cancer	7.97e-05	0.000249	CbGpPWpGaD
Pazopanib—FGFR1—Disease—EGFR—pharynx cancer	7.56e-05	0.000237	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—EGFR—pharynx cancer	7.54e-05	0.000236	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—EGFR—pharynx cancer	7.38e-05	0.000231	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—EGFR—pharynx cancer	7.36e-05	0.00023	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CCND1—pharynx cancer	7.24e-05	0.000227	CbGpPWpGaD
Pazopanib—LYN—Immune System—EGFR—pharynx cancer	7.21e-05	0.000226	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EGFR—pharynx cancer	7.2e-05	0.000225	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CCND1—pharynx cancer	7.11e-05	0.000223	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—pharynx cancer	6.94e-05	0.000217	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EGFR—pharynx cancer	6.87e-05	0.000215	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EGFR—pharynx cancer	6.8e-05	0.000213	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCND1—pharynx cancer	6.75e-05	0.000211	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCND1—pharynx cancer	6.73e-05	0.000211	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—pharynx cancer	6.2e-05	0.000194	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCND1—pharynx cancer	6.07e-05	0.00019	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—pharynx cancer	6.04e-05	0.000189	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCND1—pharynx cancer	5.94e-05	0.000186	CbGpPWpGaD
Pazopanib—LCK—Immune System—EGFR—pharynx cancer	5.91e-05	0.000185	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—pharynx cancer	5.76e-05	0.00018	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EGFR—pharynx cancer	5.68e-05	0.000178	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EGFR—pharynx cancer	5.58e-05	0.000175	CbGpPWpGaD
Pazopanib—LCK—Disease—EGFR—pharynx cancer	5.45e-05	0.000171	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EGFR—pharynx cancer	5.3e-05	0.000166	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EGFR—pharynx cancer	5.28e-05	0.000165	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCND1—pharynx cancer	4.87e-05	0.000152	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—pharynx cancer	4.77e-05	0.000149	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EGFR—pharynx cancer	4.76e-05	0.000149	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—pharynx cancer	4.69e-05	0.000147	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EGFR—pharynx cancer	4.66e-05	0.000146	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—pharynx cancer	4.45e-05	0.000139	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—pharynx cancer	4.43e-05	0.000139	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—pharynx cancer	4e-05	0.000125	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—pharynx cancer	3.91e-05	0.000122	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EGFR—pharynx cancer	3.82e-05	0.00012	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—pharynx cancer	3.21e-05	0.0001	CbGpPWpGaD
